Financhill
Buy
60

TMO Quote, Financials, Valuation and Earnings

Last price:
$575.08
Seasonality move :
9.7%
Day range:
$580.01 - $588.11
52-week range:
$385.46 - $610.97
Dividend yield:
0.29%
P/E ratio:
33.54x
P/S ratio:
5.04x
P/B ratio:
4.27x
Volume:
1.2M
Avg. volume:
1.7M
1-year change:
8.61%
Market cap:
$218.1B
Revenue:
$42.9B
EPS (TTM):
$17.31

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
TMO
Thermo Fisher Scientific, Inc.
$10.9B $5.50 4.87% 34.99% $619.96
BDSX
Biodesix, Inc.
$21M -- 21.59% -- $32.50
FONR
FONAR Corp.
-- -- -- -- --
GRAL
GRAIL, Inc.
$35.4M -$3.27 10.23% -1.26% $105.00
ISRG
Intuitive Surgical, Inc.
$2.4B $1.99 12.86% 18.99% $592.96
SHC
Sotera Health Co.
$303.7M $0.22 3.09% 462.3% $18.93
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
TMO
Thermo Fisher Scientific, Inc.
$580.45 $619.96 $218.1B 33.54x $0.43 0.29% 5.04x
BDSX
Biodesix, Inc.
$8.14 $32.50 $65.1M -- $0.00 0% 7.82x
FONR
FONAR Corp.
$14.46 -- $91M 13.07x $0.00 0% 0.88x
GRAL
GRAIL, Inc.
$101.19 $105.00 $3.9B -- $0.00 0% 24.99x
ISRG
Intuitive Surgical, Inc.
$569.71 $592.96 $202B 75.41x $0.00 0% 21.55x
SHC
Sotera Health Co.
$16.84 $18.93 $4.8B 87.25x $0.00 0% 4.18x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
TMO
Thermo Fisher Scientific, Inc.
41.15% 1.043 19.57% 0.96x
BDSX
Biodesix, Inc.
102.42% -0.860 120.74% 1.62x
FONR
FONAR Corp.
18.59% 1.654 49.09% 9.64x
GRAL
GRAIL, Inc.
2.55% 4.765 2.74% 7.26x
ISRG
Intuitive Surgical, Inc.
-- 1.065 -- 3.42x
SHC
Sotera Health Co.
80.53% 0.673 50.96% 1.99x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
TMO
Thermo Fisher Scientific, Inc.
$4.6B $2.2B 7.77% 13.15% 19.37% $1.8B
BDSX
Biodesix, Inc.
$17.7M -$7M -50.62% -333.87% -32.36% -$8.9M
FONR
FONAR Corp.
$10.4M $3.2M 4.68% 5.84% 12.26% -$636K
GRAL
GRAIL, Inc.
-$17.3M -$125.3M -16.4% -16.84% -346.17% -$63.6M
ISRG
Intuitive Surgical, Inc.
$1.7B $759.7M 16.35% 16.38% 30.33% $735.6M
SHC
Sotera Health Co.
$174.5M $125.4M 1.98% 11.79% 40.29% $33.4M

Thermo Fisher Scientific, Inc. vs. Competitors

  • Which has Higher Returns TMO or BDSX?

    Biodesix, Inc. has a net margin of 14.58% compared to Thermo Fisher Scientific, Inc.'s net margin of -40.04%. Thermo Fisher Scientific, Inc.'s return on equity of 13.15% beat Biodesix, Inc.'s return on equity of -333.87%.

    Company Gross Margin Earnings Per Share Invested Capital
    TMO
    Thermo Fisher Scientific, Inc.
    41.29% $4.28 $86.8B
    BDSX
    Biodesix, Inc.
    81.14% -$1.16 $71.2M
  • What do Analysts Say About TMO or BDSX?

    Thermo Fisher Scientific, Inc. has a consensus price target of $619.96, signalling upside risk potential of 6.81%. On the other hand Biodesix, Inc. has an analysts' consensus of $32.50 which suggests that it could grow by 299.26%. Given that Biodesix, Inc. has higher upside potential than Thermo Fisher Scientific, Inc., analysts believe Biodesix, Inc. is more attractive than Thermo Fisher Scientific, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    TMO
    Thermo Fisher Scientific, Inc.
    14 7 0
    BDSX
    Biodesix, Inc.
    4 1 0
  • Is TMO or BDSX More Risky?

    Thermo Fisher Scientific, Inc. has a beta of 0.899, which suggesting that the stock is 10.144% less volatile than S&P 500. In comparison Biodesix, Inc. has a beta of 0.625, suggesting its less volatile than the S&P 500 by 37.529%.

  • Which is a Better Dividend Stock TMO or BDSX?

    Thermo Fisher Scientific, Inc. has a quarterly dividend of $0.43 per share corresponding to a yield of 0.29%. Biodesix, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Thermo Fisher Scientific, Inc. pays 9.43% of its earnings as a dividend. Biodesix, Inc. pays out -- of its earnings as a dividend. Thermo Fisher Scientific, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TMO or BDSX?

    Thermo Fisher Scientific, Inc. quarterly revenues are $11.1B, which are larger than Biodesix, Inc. quarterly revenues of $21.8M. Thermo Fisher Scientific, Inc.'s net income of $1.6B is higher than Biodesix, Inc.'s net income of -$8.7M. Notably, Thermo Fisher Scientific, Inc.'s price-to-earnings ratio is 33.54x while Biodesix, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Thermo Fisher Scientific, Inc. is 5.04x versus 7.82x for Biodesix, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TMO
    Thermo Fisher Scientific, Inc.
    5.04x 33.54x $11.1B $1.6B
    BDSX
    Biodesix, Inc.
    7.82x -- $21.8M -$8.7M
  • Which has Higher Returns TMO or FONR?

    FONAR Corp. has a net margin of 14.58% compared to Thermo Fisher Scientific, Inc.'s net margin of 10.25%. Thermo Fisher Scientific, Inc.'s return on equity of 13.15% beat FONAR Corp.'s return on equity of 5.84%.

    Company Gross Margin Earnings Per Share Invested Capital
    TMO
    Thermo Fisher Scientific, Inc.
    41.29% $4.28 $86.8B
    FONR
    FONAR Corp.
    40.11% $0.34 $201.3M
  • What do Analysts Say About TMO or FONR?

    Thermo Fisher Scientific, Inc. has a consensus price target of $619.96, signalling upside risk potential of 6.81%. On the other hand FONAR Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Thermo Fisher Scientific, Inc. has higher upside potential than FONAR Corp., analysts believe Thermo Fisher Scientific, Inc. is more attractive than FONAR Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    TMO
    Thermo Fisher Scientific, Inc.
    14 7 0
    FONR
    FONAR Corp.
    0 0 0
  • Is TMO or FONR More Risky?

    Thermo Fisher Scientific, Inc. has a beta of 0.899, which suggesting that the stock is 10.144% less volatile than S&P 500. In comparison FONAR Corp. has a beta of 1.000, suggesting its less volatile than the S&P 500 by 0.021000000000004%.

  • Which is a Better Dividend Stock TMO or FONR?

    Thermo Fisher Scientific, Inc. has a quarterly dividend of $0.43 per share corresponding to a yield of 0.29%. FONAR Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Thermo Fisher Scientific, Inc. pays 9.43% of its earnings as a dividend. FONAR Corp. pays out -- of its earnings as a dividend. Thermo Fisher Scientific, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TMO or FONR?

    Thermo Fisher Scientific, Inc. quarterly revenues are $11.1B, which are larger than FONAR Corp. quarterly revenues of $26M. Thermo Fisher Scientific, Inc.'s net income of $1.6B is higher than FONAR Corp.'s net income of $2.7M. Notably, Thermo Fisher Scientific, Inc.'s price-to-earnings ratio is 33.54x while FONAR Corp.'s PE ratio is 13.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Thermo Fisher Scientific, Inc. is 5.04x versus 0.88x for FONAR Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TMO
    Thermo Fisher Scientific, Inc.
    5.04x 33.54x $11.1B $1.6B
    FONR
    FONAR Corp.
    0.88x 13.07x $26M $2.7M
  • Which has Higher Returns TMO or GRAL?

    GRAIL, Inc. has a net margin of 14.58% compared to Thermo Fisher Scientific, Inc.'s net margin of -245.83%. Thermo Fisher Scientific, Inc.'s return on equity of 13.15% beat GRAIL, Inc.'s return on equity of -16.84%.

    Company Gross Margin Earnings Per Share Invested Capital
    TMO
    Thermo Fisher Scientific, Inc.
    41.29% $4.28 $86.8B
    GRAL
    GRAIL, Inc.
    -47.91% -$2.46 $2.3B
  • What do Analysts Say About TMO or GRAL?

    Thermo Fisher Scientific, Inc. has a consensus price target of $619.96, signalling upside risk potential of 6.81%. On the other hand GRAIL, Inc. has an analysts' consensus of $105.00 which suggests that it could grow by 3.77%. Given that Thermo Fisher Scientific, Inc. has higher upside potential than GRAIL, Inc., analysts believe Thermo Fisher Scientific, Inc. is more attractive than GRAIL, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    TMO
    Thermo Fisher Scientific, Inc.
    14 7 0
    GRAL
    GRAIL, Inc.
    2 2 0
  • Is TMO or GRAL More Risky?

    Thermo Fisher Scientific, Inc. has a beta of 0.899, which suggesting that the stock is 10.144% less volatile than S&P 500. In comparison GRAIL, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock TMO or GRAL?

    Thermo Fisher Scientific, Inc. has a quarterly dividend of $0.43 per share corresponding to a yield of 0.29%. GRAIL, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Thermo Fisher Scientific, Inc. pays 9.43% of its earnings as a dividend. GRAIL, Inc. pays out -- of its earnings as a dividend. Thermo Fisher Scientific, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TMO or GRAL?

    Thermo Fisher Scientific, Inc. quarterly revenues are $11.1B, which are larger than GRAIL, Inc. quarterly revenues of $36.2M. Thermo Fisher Scientific, Inc.'s net income of $1.6B is higher than GRAIL, Inc.'s net income of -$89M. Notably, Thermo Fisher Scientific, Inc.'s price-to-earnings ratio is 33.54x while GRAIL, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Thermo Fisher Scientific, Inc. is 5.04x versus 24.99x for GRAIL, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TMO
    Thermo Fisher Scientific, Inc.
    5.04x 33.54x $11.1B $1.6B
    GRAL
    GRAIL, Inc.
    24.99x -- $36.2M -$89M
  • Which has Higher Returns TMO or ISRG?

    Intuitive Surgical, Inc. has a net margin of 14.58% compared to Thermo Fisher Scientific, Inc.'s net margin of 28.31%. Thermo Fisher Scientific, Inc.'s return on equity of 13.15% beat Intuitive Surgical, Inc.'s return on equity of 16.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    TMO
    Thermo Fisher Scientific, Inc.
    41.29% $4.28 $86.8B
    ISRG
    Intuitive Surgical, Inc.
    66.36% $1.95 $17B
  • What do Analysts Say About TMO or ISRG?

    Thermo Fisher Scientific, Inc. has a consensus price target of $619.96, signalling upside risk potential of 6.81%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $592.96 which suggests that it could grow by 4.08%. Given that Thermo Fisher Scientific, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe Thermo Fisher Scientific, Inc. is more attractive than Intuitive Surgical, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    TMO
    Thermo Fisher Scientific, Inc.
    14 7 0
    ISRG
    Intuitive Surgical, Inc.
    15 10 1
  • Is TMO or ISRG More Risky?

    Thermo Fisher Scientific, Inc. has a beta of 0.899, which suggesting that the stock is 10.144% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.249%.

  • Which is a Better Dividend Stock TMO or ISRG?

    Thermo Fisher Scientific, Inc. has a quarterly dividend of $0.43 per share corresponding to a yield of 0.29%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Thermo Fisher Scientific, Inc. pays 9.43% of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend. Thermo Fisher Scientific, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TMO or ISRG?

    Thermo Fisher Scientific, Inc. quarterly revenues are $11.1B, which are larger than Intuitive Surgical, Inc. quarterly revenues of $2.5B. Thermo Fisher Scientific, Inc.'s net income of $1.6B is higher than Intuitive Surgical, Inc.'s net income of $709.2M. Notably, Thermo Fisher Scientific, Inc.'s price-to-earnings ratio is 33.54x while Intuitive Surgical, Inc.'s PE ratio is 75.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Thermo Fisher Scientific, Inc. is 5.04x versus 21.55x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TMO
    Thermo Fisher Scientific, Inc.
    5.04x 33.54x $11.1B $1.6B
    ISRG
    Intuitive Surgical, Inc.
    21.55x 75.41x $2.5B $709.2M
  • Which has Higher Returns TMO or SHC?

    Sotera Health Co. has a net margin of 14.58% compared to Thermo Fisher Scientific, Inc.'s net margin of 15.55%. Thermo Fisher Scientific, Inc.'s return on equity of 13.15% beat Sotera Health Co.'s return on equity of 11.79%.

    Company Gross Margin Earnings Per Share Invested Capital
    TMO
    Thermo Fisher Scientific, Inc.
    41.29% $4.28 $86.8B
    SHC
    Sotera Health Co.
    56.04% $0.17 $2.8B
  • What do Analysts Say About TMO or SHC?

    Thermo Fisher Scientific, Inc. has a consensus price target of $619.96, signalling upside risk potential of 6.81%. On the other hand Sotera Health Co. has an analysts' consensus of $18.93 which suggests that it could grow by 12.4%. Given that Sotera Health Co. has higher upside potential than Thermo Fisher Scientific, Inc., analysts believe Sotera Health Co. is more attractive than Thermo Fisher Scientific, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    TMO
    Thermo Fisher Scientific, Inc.
    14 7 0
    SHC
    Sotera Health Co.
    4 3 0
  • Is TMO or SHC More Risky?

    Thermo Fisher Scientific, Inc. has a beta of 0.899, which suggesting that the stock is 10.144% less volatile than S&P 500. In comparison Sotera Health Co. has a beta of 1.815, suggesting its more volatile than the S&P 500 by 81.485%.

  • Which is a Better Dividend Stock TMO or SHC?

    Thermo Fisher Scientific, Inc. has a quarterly dividend of $0.43 per share corresponding to a yield of 0.29%. Sotera Health Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Thermo Fisher Scientific, Inc. pays 9.43% of its earnings as a dividend. Sotera Health Co. pays out -- of its earnings as a dividend. Thermo Fisher Scientific, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TMO or SHC?

    Thermo Fisher Scientific, Inc. quarterly revenues are $11.1B, which are larger than Sotera Health Co. quarterly revenues of $311.3M. Thermo Fisher Scientific, Inc.'s net income of $1.6B is higher than Sotera Health Co.'s net income of $48.4M. Notably, Thermo Fisher Scientific, Inc.'s price-to-earnings ratio is 33.54x while Sotera Health Co.'s PE ratio is 87.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Thermo Fisher Scientific, Inc. is 5.04x versus 4.18x for Sotera Health Co.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TMO
    Thermo Fisher Scientific, Inc.
    5.04x 33.54x $11.1B $1.6B
    SHC
    Sotera Health Co.
    4.18x 87.25x $311.3M $48.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
65
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock